Clinical Trial

Penthrox in Otolaryngology

Study acronym: PenthroxOTL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Our objective is to explore the use of methoxyflurane anesthesia as an adjunct analgesic to local anesthesia during in-office otolaryngology procedures in a prospective pilot study. The main outcome of this study will be patient satisfaction with the medication and analgesia. Secondary outcomes will include level of sedation and analgesia, patient-reported post-procedural pain levels, and any reported adverse events.
Trial Details
NCT Number NCT07003880
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions All Adult Patients Undergoing an Otolaryngology Procedure With Inhaled Methoxyflurane as an Adjunct to Topical or Local Anesthesia
Enrollment 50 participants
Start Date 2025-06-01
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-04